Abstract
[This corrects the article DOI: 10.3389/fped.2018.00316.].
Highlights
Daniel Ebrahimi-Fakhari 1*, Ulrich Dillmann 2, Marina Flotats-Bastardas 1, Martin Poryo 3, Hashim Abdul-Khaliq 3, Mohammed Ghiath Shamdeen 4, Bernhard Mischo 4, Michael Zemlin 1 and Sascha Meyer 1
Specialty section: This article was submitted to Pediatric Neurology, a section of the journal Frontiers in Pediatrics
Due to reasons stated above, a correction has been made to the Abstract: “About 15% of Duchenne muscular dystrophy (DMD) cases are caused by point mutations leading to premature stop codons and disrupted synthesis of the dystrophin protein
Summary
Daniel Ebrahimi-Fakhari 1*, Ulrich Dillmann 2, Marina Flotats-Bastardas 1, Martin Poryo 3, Hashim Abdul-Khaliq 3, Mohammed Ghiath Shamdeen 4, Bernhard Mischo 4, Michael Zemlin 1 and Sascha Meyer 1. Corrigendum: Off-Label Use of Ataluren in Four Non-ambulatory Patients With Duchenne Muscular Dystrophy: Effects on Cardiac and Pulmonary Function and Muscle Strength Off-Label Use of Ataluren in Four Non-ambulatory Patients With Duchenne Muscular Dystrophy: Effects on Cardiac and Pulmonary Function and Muscle Strength by Ebrahimi-Fakhari, D., Dillmann, U., Flotats-Bastardas, M., Poryo, M., Abdul-Khaliq, H., Shamdeen, M.
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
